revolade
novartis europharm limited - eltrombopag - purpura, trombocytopenická, idiopatická - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 a 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 a 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.
sandimmun 50 mg/ml
novartis slovakia s.r.o., slovensko - cyklosporín - 59 - immunopraeparata
maalox žuvacie tablety
opella healthcare slovakia s.r.o., slovensko - zlúčeniny hliníka, kombinácie - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
maalox bez cukru s príchuťou citróna
opella healthcare slovakia s.r.o., slovensko - zlúčeniny hliníka, kombinácie - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
maalox premium
opella healthcare slovakia s.r.o., slovensko - zlúčeniny hliníka, kombinácie - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
gattart 680 mg/80 mg
alkaloid - int d.o.o., slovinsko - kombinácia bežných solí - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
mavenclad
merck europe b.v. - cladribine - roztrúsená skleróza - imunosupresíva - liečba dospelých pacientov s vysoko aktívnou recidivujúcou sklerózou multiplex (ms), ako je definované klinickými alebo zobrazovacími znakmi.
qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinálne stromálne nádory - antineoplastické činidlá - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
rennie s príchuťou pomaranča 680 mg/80 mg žuvacie tablety
bayer, spol. s r.o., slovensko - kombinácia bežných solí - 09 - antacida (vrÁtane antiulcerosnych lieČiv)
rennie plus 625 mg/73,5 mg/150 mg žuvacie tablety
bayer, spol. s r.o., slovensko - antacidá, iné kombinácie - 09 - antacida (vrÁtane antiulcerosnych lieČiv)